$GERN Recent News Charting the latest market whi
Post# of 88933
Charting the latest market whipsaw 10:59 a.m. Nov. 11, 2013 - Michael Ashbaugh
Oracle active, Geron shares fall after hours 6:06 p.m. Dec. 3, 2012 - Carla Mozee
Geron to discontinue brain-cancer drug development 4:38 p.m. Dec. 3, 2012 - MarketWatch.com
BioTime offers equity stake for Geron assets 8:47 a.m. Oct. 18, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Geron ends breast cancer study of Imetelstat 7:06 a.m. Sept. 10, 2012 - MarketWatch.com
Stocks to Watch Friday: Splunk, Zumiez, Pandora 3:59 p.m. Aug. 30, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:31 p.m. Aug. 30, 2012 - MarketWatch
Geron climbs 11% on analyst rating 9:56 a.m. Aug. 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Nov. 15, 2011 - Kate Gibson
Financial uncertainty nixed Geron stem cell work 2:09 p.m. Nov. 15, 2011 - MarketWatch.com
Stocks to watch Friday: Global Crossing, Clarcor 5:42 a.m. Sept. 30, 2011 - MarketWatch
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Amylin and Alkermes shine in drug-stocks trading 2:08 p.m. July 8, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Regeneron, Cephalon boost biotech stocks 2:29 p.m. May 2, 2011 - Val Brickates Kennedy
Stem cell researchers gain on U.S. court decision 9:14 a.m. May 2, 2011 - Val Brickates Kennedy
StemCells shares climb on spinal injury study 2:49 p.m. March 14, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:09 p.m. Dec. 7, 2010 - Kate Gibson
Not much new in Mayo Geron article: Needham 9:52 a.m. Dec. 6, 2013 - Seeking Alpha
Today's Pre-Market Mover With Heavy Volume: Geron Corporation (GERN) 8:35 a.m. Dec. 6, 2013 - TheStreet.com
Mayo Clinic study boosts Geron 8:25 a.m. Dec. 6, 2013 - Seeking Alpha
Geron's CEO Presents at 25th Annual Piper Jaffray Healthcare Conference (Transcript) 6:46 p.m. Dec. 4, 2013 - Seeking Alpha
Geron Corporation (GERN) In A Perilous Reversal 1:31 p.m. Dec. 3, 2013 - TheStreet.com
Interesting GERN Put And Call Options For January 2014 12:43 p.m. Nov. 19, 2013 - TheStreet.com
3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference 5:38 a.m. Nov. 19, 2013 - Seeking Alpha
Perilous Reversal Stock: Geron Corporation (GERN) 9:50 a.m. Nov. 15, 2013 - TheStreet.com
Interesting GERN Call Options For January 2016 12:44 p.m. Nov. 11, 2013 - TheStreet.com
Geron: Hold Or Take Profits Now? 10:17 a.m. Nov. 11, 2013 - Seeking Alpha
Geron Q3 Loss in Line; Shares Up on ASH Abstract - Analyst Blog 10:00 a.m. Nov. 11, 2013 - Zacks.com
Geron: A Changed Company With Significant Potential 9:59 a.m. Nov. 11, 2013 - Seeking Alpha
Multiple Reasons To Buy Incyte 3:25 p.m. Nov. 8, 2013 - Seeking Alpha
The 10 Dumbest Things This Friday 12:14 p.m. Nov. 8, 2013 - 247WallSt.com
Geron's Promising News Poses No Threat To Incyte 11:53 a.m. Nov. 8, 2013 - Seeking Alpha
Interesting GERN Put And Call Options For January 2015 11:08 a.m. Nov. 8, 2013 - TheStreet.com
Geron Corporation (GERN) Is Today's Perilous Reversal Stock 9:46 a.m. Nov. 8, 2013 - TheStreet.com
Key Issues Surrounding The Zalicus Catalyst Trade 8:56 a.m. Nov. 8, 2013 - Seeking Alpha
Quick Take On Geron's Imetelstat Abstract 9:17 p.m. Nov. 7, 2013 - Seeking Alpha
Geron Management Discusses Q3 2013 Results - Earnings Call Transcript 7:10 p.m. Nov. 7, 2013 - Seeking Alpha
Top Gainers & Losers: InterOil Corporation, Geron Corporation, Amazon.com, ZIOPHARM Oncology Inc 9:47 a.m. Dec. 6, 2013 - ACCESSWIRE
Geron to Host Analyst and Investor Meeting on December 9 7:31 a.m. Dec. 5, 2013 - Thomson Reuters ONE
Announcements and Sponsorships by Biotechnology Companies and Major Drug Manufacturers - Research Report on Lilly, Geron, MannKind, Techne, and InterMune 8:00 a.m. Dec. 2, 2013 - PR Newswire
Geron to Present at the Piper Jaffray Healthcare Conference 7:31 a.m. Nov. 26, 2013 - Thomson Reuters ONE
Early Briefing and Review: Arena Pharma Inc., Geron Corp., Incyte Corp., and Spectrum Pharma Inc. 1:31 p.m. Nov. 22, 2013 - PR Newswire
Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena 8:00 a.m. Nov. 12, 2013 - PR Newswire
Earning Forecast Tips for Hot Stocks: Facebook, Tesla, J.C. Penney, Groupon, Geron, and Alcoa 9:00 a.m. Nov. 8, 2013 - PR Newswire
TrendingWallStreet.com Initiates Volume Analysis on TWTR, FNMA, SEEK, and GERN 12:19 a.m. Nov. 8, 2013 - ACCESSWIRE
Geron Corporation Reports Third Quarter 2013 Financial Results 4:11 p.m. Nov. 7, 2013 - Thomson Reuters ONE
WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR 10:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Geron Announces Conference Call to Discuss Third Quarter 2013 Financial Results 3:01 p.m. Nov. 1, 2013 - Thomson Reuters ONE
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 8:00 a.m. Oct. 31, 2013 - PR Newswire
Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences 7:00 a.m. Oct. 21, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 8:26 a.m. Oct. 8, 2013 - PR Newswire
TSLA, AGNC, GERN and ZLCS added to Nasdaq Active Stock Watch List at GSR 8:05 a.m. Oct. 1, 2013 - ACCESSWIRE
Geron Completes Divestiture of Stem Cell Assets 8:01 a.m. Oct. 1, 2013 - Thomson Reuters ONE
Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Acquires Geron's Embryonic Stem Cell Assets 8:00 a.m. Oct. 1, 2013 - BusinessWire
FSLR, LINE, GERN and CLDX added to NASDAQ Active Stock Watch List at EPR 8:05 a.m. Sept. 24, 2013 - ACCESSWIRE
Edge Therapeutics Elects Robert J. Spiegel, MD To Board of Directors 5:30 a.m. Sept. 10, 2013 - BusinessWire
Geron to Present at the Stifel Healthcare Conference 3:00 p.m. Sept. 4, 2013 - Thomson Reuters ONE